From Google Scholar Alerts
Please note that some are abstracts requiring subscriptions or purchase of the full article, others provide a more comprehensive view of the paper.

Parapharyngeal Malignant Ectomesenchymoma. Controversies on Diagnostic and Clinical Approach of a Pediatric Case
M Silveri, A Camaioni, M Trozzi, F Tucci, R Boldrini… - Journal of Pediatric …, 2014
... Abstract: In Malignant Ectomesenchymoma (MEM), mesenchymal (usually rhabdomyosarcoma)
and neural (usually ganglion cells and/or neuroblasts) elements are copresent. ... Keywords: Soft
tissue sarcoma, rhabdomyosarcoma, surgery, rare tumors. INTRODUCTION ...

INTENSITY MODULATED RADIATION THERAPY IN PEDIATRIC CANCER; CLINICAL OUTCOME AND RISK OF RADIATION-INDUCED MALIGNANCIES
N Suntornpong - Siriraj Medical Journal, 2015
... Although the risk of secondary malignancies may be increased by IMRT, the outcome
in pediatric cancers such as neuroblastoma, rhabdomyosarcoma and medulloblastoma
have been reported with acceptable local control and toxicities. ...

Association of an Inherited Genetic Variant With Vincristine-Related Peripheral Neuropathy in Children With Acute Lymphoblastic Leukemia
B Diouf, KR Crews, G Lew, D Pei, C Cheng, J Bao… - JAMA, 2015
Research from JAMA — Association of an Inherited Genetic Variant With Vincristine-Related
Peripheral Neuropathy in Children With Acute Lymphoblastic Leukemia.

Sox10-A Marker for Not Only Schwannian and Melanocytic Neoplasms But Also Myoepithelial Cell Tumors of Soft Tissue: A Systematic Analysis of 5134 Tumors.
M Miettinen, PA McCue, M Sarlomo-Rikala, W Biernat… - The American Journal of …, 2015
... Sox10 was virtually absent in mesenchymal tumors but occasionally seen in alveolar
rhabdomyosarcoma. In epithelial tumors of soft tissue, Sox10 was expressed only in
myoepitheliomas, although often absent in malignant variants. ...

Organ-specific PTB1-associated microRNAs determine expression of pyruvate kinase isoforms
K Taniguchi, Y Ito, N Sugito, M Kumazaki, H Shinohara… - Scientific Reports, 2015
... DLD-1 and WiDr, human colon cancer cell lines; NB-9 and IMR-32, human neuroblastoma cell lines; MKN-45 and KATO-3, human gastric cancer cell lines; KYM-1 and RD, human
rhabdomyosarcoma cell lines; K562, human chronic myelogenous leukemia cell line; THP-1 ...

Cutaneous extrarenal rhabdoid tumor in a dog: a case report
HJ Kim, EJ Choi, HR Lee, BT Kwon, SH Do - Veterinarni Medicina, 2015
... 2013). Histologically, RTs are characterised by sheets of highly pleomorphic “rhabdoid” cells which resem- ble rhabdomyosarcoma under the light microscope and which rely on the presence of large epithelioid cells with eccentric eosinophilic cytoplasm, vesicular nuclei, and ...

Novel ALK inhibitors in clinical use and development
C Iragavarapu, M Mustafa, A Akinleye, M Furqan… - Journal of Hematology & …, 2015
... ALK mutations have also been implicated in the pathogenesis of rhabdomyosarcoma [5],
inflammatory myofibroblastic pseudo tumor [6], neuroblastoma [7] and non-small cell lung Cancer [8]. In this article, we discussed common ALK mutations and provided a review of ALK-1 ...

Mdm2 Promotes Myogenesis through the Ubiquitination and Degradation of CCAAT/Enhancer Binding Protein β
D Fu, N Lala-Tabbert, H Lee, N Wiper-Bergeron - Journal of Biological Chemistry, 2015
... High levels of Mdm2 have also been shown to block myogenesis in rhabdomyosarcoma
cell lines and C2C12 myoblasts (37). Given the important roles attributed to Mdm2, it is
perhaps not surprising that the expression of Mdm2 has to be Page 7. ...

RHABDOMYOSARCOMA OF THE UPPER LIP IN AN ADULT PATIENT (CASE REPORT)
Bengu Cobanoglu1, Mustafa Simsek2, Serkan Senol1, 1Department of Pathology, Istanbul MedeniyetUniversity, Goztepe Education and Reserach Hospital; 2Department of ...

Differences in the responses and prognoses of pazopanib to soft tissue sarcomas by their histological eligibility for the PALETTE study
K Nakano, N Motoi, L Inagaki, J Tomomatsu, T Gokita… - Japanese Journal of Clinical …, 2015
... Maurer HM,; Anderson JR,; et al. . The Intergroup Rhabdomyosarcoma Study Group
(IRSG): major lessons from the IRS-I through IRS-IV studies as background for the
current IRS-V treatment protocols. Sarcoma 2001;5:9-15. ...